The Future of Access: 2025 Hawaiʻi Liver Summit @8:30AM HST
Flyer for Hawai’i Liver Summit 2025
Our annual liver summit is back on December 6, 2025!
Early bird registration is now open, with 50% discount for healthcare professionals and free registration for students, patients, and caregivers. Conference fee includes continuing education credits (if needed) as well as networking breakfast and lunch.
This year’s theme is “The Future of Access,” which will feature real stories and cases of care and treatment access for liver diseases, including:
viral hepatitis B and C;
fatty liver (MASH/MASLD);
liver cancer prevention;
patient perspectives;
artificial intelligence;
LGBTQ+ and rural communities.
We are expecting at least 100 summit attendees at the University of Hawai‘i at Mānoa John A. Burns School of Medicine (JABSOM) Auditorium for this full day CME / CE* event. This summit is intended for physicians, nurses, pharmacists, patients, caregivers, and students. For more info, please email Amy Trang, PhD at administrator@hepBtaskforce.org.
*In support of improving patient care, this activity has been planned and implemented by the Hawaiʻi Public Health Institute and the Western Region Public Health Training Center (WRPHTC). The WRPHTC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (APCE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
HEP-DART 2025 - Day 1
“We are pleased to announce Hep-DART 2025 will be held at the Hilton Hawaiian Village from December 7-11, 2025 in Honolulu, Hawaii.
This year will mark the 30th anniversary for the conference.
The DART series is and in-person meeting designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders in their field, benefiting from educational feedback on their work.
The aim of HEP-DART 2025 is to assemble clinicians, researchers, basic scientists, nurses and physician assistants together to advance our knowledge of the ongoing drug development processes in the treatment of viral hepatitis (HBV, HCV, HDV, HAV and HEV), metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and hepatocellular carcinoma (HCC). This CME-accredited workshop will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community with an increased understanding of the current and future challenges in therapeutics for liver infection, disease and cancer.
We hope to see you in December!”
HEP-DART 2025 - Day 2
“We are pleased to announce Hep-DART 2025 will be held at the Hilton Hawaiian Village from December 7-11, 2025 in Honolulu, Hawaii.
This year will mark the 30th anniversary for the conference.
The DART series is and in-person meeting designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders in their field, benefiting from educational feedback on their work.
The aim of HEP-DART 2025 is to assemble clinicians, researchers, basic scientists, nurses and physician assistants together to advance our knowledge of the ongoing drug development processes in the treatment of viral hepatitis (HBV, HCV, HDV, HAV and HEV), metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and hepatocellular carcinoma (HCC). This CME-accredited workshop will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community with an increased understanding of the current and future challenges in therapeutics for liver infection, disease and cancer.
We hope to see you in December!”
Hep Free 2030: Advocacy Workgroup @3PM HST
Letʻs ADVOCATE!
Join our monthly Advocacy workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Advocacy workgroup focuses on projects related to legislation, policy, insurance coverage, and more!
This workgroup usually meets every 2nd Monday. For more info on joining, email Aaron Ruddick: aruddick@hhhrc.org
HEP-DART 2025 - Day 3
“We are pleased to announce Hep-DART 2025 will be held at the Hilton Hawaiian Village from December 7-11, 2025 in Honolulu, Hawaii.
This year will mark the 30th anniversary for the conference.
The DART series is and in-person meeting designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders in their field, benefiting from educational feedback on their work.
The aim of HEP-DART 2025 is to assemble clinicians, researchers, basic scientists, nurses and physician assistants together to advance our knowledge of the ongoing drug development processes in the treatment of viral hepatitis (HBV, HCV, HDV, HAV and HEV), metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and hepatocellular carcinoma (HCC). This CME-accredited workshop will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community with an increased understanding of the current and future challenges in therapeutics for liver infection, disease and cancer.
We hope to see you in December!”
Prevent Cancer Community Exchange Part 2 - Viral Hep and Liver Cancer
“Overview of hepatitis A, B, C, and D viruses and their links to liver cancer and updates on evidence-based practices in screening and early detection. This session will also highlight disparities in viral hepatitis and liver cancer diagnoses and outcomes among populations at increased risk.”
Hep Free 2030: Awareness Workgroup @11AM HST
Letʻs get AWARE!
Join our monthly Awareness workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Awareness workgroup focuses on projects related to social and traditional media, storytelling, provider and general education, and more!
This workgroup usually meets every 2nd Tuesday. For more info on joining, email Anika Martin: amartin@hhhrc.org
Hep Free 2030: Monthly Update @12PM HST
We wanna hear from you!
Learn and share at our monthly Zoom meeting on Hep Free 2030, the Hawai’i statewide hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Each month has two meeting options every 2nd Tuesday at 12 pm HST and 5 pm HST. For Zoom meeting info, email Thaddeus Pham: thaddeus.pham@doh.hawaii.gov
Hep Free 2030: Monthly Update @5PM HST
We wanna hear from you!
Learn and share at our monthly Zoom meeting on Hep Free 2030, the Hawai’i statewide hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Each month has two meeting options every 2nd Tuesday at 12 pm HST and 5 pm HST. For Zoom meeting info, email Thaddeus Pham: thaddeus.pham@doh.hawaii.gov
HEP-DART 2025 - Day 4
“We are pleased to announce Hep-DART 2025 will be held at the Hilton Hawaiian Village from December 7-11, 2025 in Honolulu, Hawaii.
This year will mark the 30th anniversary for the conference.
The DART series is and in-person meeting designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders in their field, benefiting from educational feedback on their work.
The aim of HEP-DART 2025 is to assemble clinicians, researchers, basic scientists, nurses and physician assistants together to advance our knowledge of the ongoing drug development processes in the treatment of viral hepatitis (HBV, HCV, HDV, HAV and HEV), metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and hepatocellular carcinoma (HCC). This CME-accredited workshop will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community with an increased understanding of the current and future challenges in therapeutics for liver infection, disease and cancer.
We hope to see you in December!”
HEP-DART 2025 - Day 5
“We are pleased to announce Hep-DART 2025 will be held at the Hilton Hawaiian Village from December 7-11, 2025 in Honolulu, Hawaii.
This year will mark the 30th anniversary for the conference.
The DART series is and in-person meeting designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders in their field, benefiting from educational feedback on their work.
The aim of HEP-DART 2025 is to assemble clinicians, researchers, basic scientists, nurses and physician assistants together to advance our knowledge of the ongoing drug development processes in the treatment of viral hepatitis (HBV, HCV, HDV, HAV and HEV), metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and hepatocellular carcinoma (HCC). This CME-accredited workshop will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community with an increased understanding of the current and future challenges in therapeutics for liver infection, disease and cancer.
We hope to see you in December!”
Hep B Functional Cure: Progress @12AM HST
Hepatitis B functional cure: what does it mean and how close are we to reaching it?
"New innovations are bringing us closer than ever to a functional cure for hepatitis B, which could be transformative for people living with hepatitis B. Given the new advancements in research, the World Hepatitis Alliance is hosting a webinar to provide an overview of what a functional cure is and the science driving its development. The webinar will explore the types of treatment that are currently in the clinical pipeline and what achieving a functional cure could mean for people living with hepatitis B.
Supported by Aligos Therapeutics and Virion Therapeutics”
Hep Free 2030: Access Workgroup @12PM HST
Letʻs get ACCESS!
Join our monthly Access workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Access workgroup focuses on projects related to immunization, testing, linkage, treatment, and provider education!
This workgroup usually meets every 3rd Tuesday. For more info on joining, email Thaddeus Pham: thaddeus.pham@doh.hawaii.gov
Hep Free 2030: Equity Workgroup @12PM HST
Letʻs get EQUITY!
Join our monthly Equity workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Equity workgroup focuses on projects related to language access, patient leadership, community centering, and people with lived experience.
This workgroup usually meets every 3rd Wednesday. For more info on joining, email Richard Smith: richawaii78@gmail.com
National Viral Hep Roundtable Network @10AM
“Welcome back to the monthly NVHR Call! After a brief hiatus, we are thrilled to return with monthly webinars on the 3rd Thursday of each month at 3pm ET/12pm PT. They are open to anyone interested in viral hepatitis updates…
Please email info@nvhr.org for any questions or difficulty registering.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
Know Your Rights from Hep B Foundation @7AM HST
“Join us for an important and empowering Know Your Rights Webinar, featuring an experienced immigrant rights lawyer from a respected social justice organization. This session will break down what rights immigrants have and how to protect themselves and their communities. Date: Dec 3rd at 12pm ET”
Hep Free 2030: Data Workgroup @12PM HST
Letʻs get DATA!
Join our monthly Data workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Data workgroup focuses on projects related to surveillance, electronic reporting, qualitative research, and more!
This workgroup usually meets every 1st Tuesday. For more info on joining, email Myriam Saboui: myriam.saboui@doh.hawaii.gov.
World AIDS Day Hawaiʻi @5PM HST
“Join us for World AIDS Day Hawai’i 2025, a time for our community to come together in remembrance, reflection, and renewed commitment to health equity and compassion.
The evening will begin with a community reception featuring light refreshments, followed by a memorial program honoring the lives lost to HIV/AIDS and celebrating the ongoing work toward a future free of stigma and discrimination.
This year, the Hawai’i Department of Health will be honoring Kunane Dreier as the recipient of the 2025 Suzanne Richmond-Crum Award in recognition of his outstanding leadership, advocacy, and lifelong dedication to Hawaiʻi’s HIV and LGBTQIA+ communities.
Hosted by the Hawaiʻi Health & Harm Reduction Center (H3RC) in partnership with Church of the Crossroads, this annual gathering invites community members, advocates, and allies to stand together in solidarity and celebrate the power of hope, healing, and human connection.
All are welcome.
Event Details:
Date: December 1
Time: 5 – 6 pm Reception | 6 – 7:30 pm Program
Location: Church of the Crossroads (1212 University Avenue)”
Prevent Cancer Community Exchange Part 1 - Intro to NASTAD @11AM HST
“Learn about NASTAD’s services, specifically capacity building and technical assistance for viral hepatitis programs implementing prevention and surveillance activities within their jurisdictions and about NASTAD’s policy and legislative affairs, such as local, state, and national policy initiatives and how you can get involved.”
National Viral Hep Roundtable Network @10AM
“Welcome back to the monthly NVHR Call! After a brief hiatus, we are thrilled to return with monthly webinars on the 3rd Thursday of each month at 3pm ET/12pm PT. They are open to anyone interested in viral hepatitis updates…
Please email info@nvhr.org for any questions or difficulty registering.”
Triple Elimination of Hep B, HIV, Syphilis @3AM HST
World Hepatitis Testing Week: Scaling up hepatitis B within triple elimination programmes
“Triple elimination of the vertical transmission (EVT) of HIV, syphilis and hepatitis B will save thousands of lives each year. Triple elimination programmes are also key to achieving hepatitis elimination. By simplifying access to testing for pregnant women, triple elimination enables timely interventions to prevent vertical transmission – the most common cause of chronic hepatitis B. It is also a gateway to family testing, ensuring that more people living with hepatitis B are diagnosed and linked to treatment and care. As part of World Hepatitis Testing Week, the World Hepatitis Alliance is hosting a webinar to explore the critical role of triple elimination as part of comprehensive hepatitis programmes. It will discuss different approaches to scaling up EVT services and how different stakeholders can collectively work together to drive progress towards triple elimination. Supported by Abbott”
Hep Free 2030: Equity Workgroup @12PM HST
Letʻs get EQUITY!
Join our monthly Equity workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Equity workgroup focuses on projects related to language access, patient leadership, community centering, and people with lived experience.
This workgroup usually meets every 3rd Wednesday. For more info on joining, email Richard Smith: richawaii78@gmail.com
Point-of-Care Hep C Testing in Syringe Services Programs @8AM HST
“In the United States, there are an estimated 69,000 new hepatitis C (HCV) cases annually, most of which are linked to injection drug use. Historically, HCV diagnosis has required a two-step process: an antibody test followed by a confirmatory RNA test, with results often taking days or even weeks to return. In 2024, the U.S. Food and Drug Administration (FDA) approved Cepheid’s Xpert HCV test, the first point-of-care HCV RNA test, marking a major milestone for public health. This advancement allows for same-day diagnosis in under an hour, bridging critical gaps in the HCV testing and care continuum and creating new opportunities for timely linkage to care. Join us on Wednesday, November 19 at 1:00 PM ET for a webinar featuring insights from Public Health – Seattle & King County, one of the first jurisdictions in the country to implement the Xpert HCV test within a syringe services program (SSP). The study’s lead will: • Describe the protocol for conducting HCV point-of-care testing in an SSP setting • Share findings from an implementation study involving 200 people who use drugs tested for HCV • Highlight key facilitators and challenges encountered during implementation • Discuss strategies for pairing HCV point-of-care testing with linkage-to-care efforts This session will offer practical insights for health departments, harm reduction programs, and community partners interested in expanding rapid, low-barrier HCV testing models to improve diagnosis and treatment outcomes.”
Hep C RNA Point of Care in Syringe Exchanges @8AM HST
“In the United States, there are an estimated 69,000 new hepatitis C (HCV) cases annually, most of which are linked to injection drug use. Historically, HCV diagnosis has required a two-step process: an antibody test followed by a confirmatory RNA test, with results often taking days or even weeks to return. In 2024, the U.S. Food and Drug Administration (FDA) approved Cepheid’s Xpert HCV test, the first point-of-care HCV RNA test, marking a major milestone for public health. This advancement allows for same-day diagnosis in under an hour, bridging critical gaps in the HCV testing and care continuum and creating new opportunities for timely linkage to care.
Join us on Wednesday, November 19 at 1:00 PM ET for a webinar featuring insights from Public Health – Seattle & King County, one of the first jurisdictions in the country to implement the Xpert HCV test within a syringe services program (SSP). The study’s lead will:
Describe the protocol for conducting HCV point-of-care testing in an SSP setting
Share findings from an implementation study involving 200 people who use drugs tested for HCV
Highlight key facilitators and challenges encountered during implementation
Discuss strategies for pairing HCV point-of-care testing with linkage-to-care efforts
This session will offer practical insights for health departments, harm reduction programs, and community partners interested in expanding rapid, low-barrier HCV testing models to improve diagnosis and treatment outcomes.”
CANCELED - Hep Free 2030: Access Workgroup @12PM HST
Letʻs get ACCESS!
Join our monthly Access workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Access workgroup focuses on projects related to immunization, testing, linkage, treatment, and provider education!
This workgroup usually meets every 3rd Tuesday. For more info on joining, email Thaddeus Pham: thaddeus.pham@doh.hawaii.gov
NEW DATE - Hep Free 2030: Advocacy Workgroup @3PM HST
Letʻs ADVOCATE!
Join our monthly Advocacy workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Advocacy workgroup focuses on projects related to legislation, policy, insurance coverage, and more!
This workgroup usually meets every 2nd Monday. For more info on joining, email Aaron Ruddick: aruddick@hhhrc.org
NEW DATE - Hep Free 2030: Monthly Update @5PM HST
We wanna hear from you!
Learn and share at our monthly Zoom meeting on Hep Free 2030, the Hawai’i statewide hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Each month has two meeting options every 2nd Tuesday at 12 pm HST and 5 pm HST. For Zoom meeting info, email Thaddeus Pham: thaddeus.pham@doh.hawaii.gov
NEW DATE - Hep Free 2030: Monthly Update @12PM HST
We wanna hear from you!
Learn and share at our monthly Zoom meeting on Hep Free 2030, the Hawai’i statewide hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Each month has two meeting options every 2nd Tuesday at 12 pm HST and 5 pm HST. For Zoom meeting info, email Thaddeus Pham: thaddeus.pham@doh.hawaii.gov
Scaling Up Hep Delta Testing @3AM HST
“Globally, it is estimated that 12 million people are living with hepatitis delta. Although hepatitis delta accounts for approximately 20% of liver disease, access to screening and treatment is largely unavailable. With exciting developments in the treatment pipeline, it is more critical than ever that we increase diagnosis rates and address the existing barriers to scaling up testing. As part of World Hepatitis Testing Week, the World Hepatitis Alliance is hosting a webinar to explore the current testing landscape for hepatitis delta, the existing recommendations and guidelines, barriers to testing, and actionable next steps for scale up. Supported by Bluejay Therapeutics”
Hep B Birth Dose Town Hall @10AM HST
“Join us for a virtual town hall to explore recent hepatitis B developments from the Advisory Committee on Immunization Practices (ACIP). This event will provide an open forum for a comprehensive Q&A session covering potential ACIP outcomes, the significance of the hepatitis B birth dose, and collaborative efforts to guarantee that every child has access to the hepatitis B vaccine.”
Hep Free 2030: Awareness Workgroup @11AM HST
Letʻs get AWARE!
Join our monthly Awareness workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Awareness workgroup focuses on projects related to social and traditional media, storytelling, provider and general education, and more!
This workgroup usually meets every 2nd Tuesday. For more info on joining, email Anika Martin: amartin@hhhrc.org
Community-Led Hep Testing Workshop @6AM HST
“In the run up to World Hepatitis Testing Week, WHA is excited to host a practical workshop on community-led testing.
The workshop will be delivered three times: once each in English, French, and Spanish. By the end, participants will:
Understand the different testing available for viral hepatitis
Be aware of the cost of testing for viral hepatitis
Understand how testing works in practice
Understand the principles of community-based testing and how to implement them effectively
You can sign up below – we look forward to seeing you!”
12th Intl HBV Cure Workshop in Washington, DC
“The 12th International HBV Cure Workshop 2025 is scheduled to be held in Washington, D.C. on November 5, 2025, right before the AASLD liver meeting. This workshop also brings together global inter-disciplinary experts to provide a framework for how academia and industry should collaborate to achieve the goal of curing hepatitis B.
Since its inception in 2014, the International HBV Cure Workshop has been a pivotal scientific platform aimed at accelerating the progress towards finding a cure for HBV. With over 250 million people worldwide living with hepatitis B, the workshop's goal is to update participants on the latest advancements in HBV cure research. The event will be highly interactive, featuring contributions from experts in basic, translational, and clinical HBV research.
The HBV treatment landscape is experiencing significant transformations and is on the brink of a paradigm shift. The emergence of numerous new treatment options brings great hope for reducing the disease burden, simplifying treatment protocols, and potentially curing and eradicating HBV infection. To optimize curative treatments for HBV, distinguished speakers from around the world will present the latest therapeutic options for viral hepatitis. Experts will discuss the path forward to curing this deadly disease, which can lead to liver cirrhosis and liver cancer. Extensive discussions will cover the appropriate endpoints for therapeutic trials and the combination of different agents targeting the virus and/or immune system. This workshop also serves as a platform for global interdisciplinary experts to provide a framework for collaboration between academia and industry, with the ultimate goal of curing hepatitis B.
We look forward to seeing you in DC!”
Hep D and Liver Cancer @5AM HST
“Please join us for Hepatitis Delta Connect's fall webinar, where we will hear from Professor Francesco Negro, presenting on hepatitis delta infection and the recent reclassification of hepatitis delta as carcinogenic by WHO. We will also hear from Rav Yakubov and Dan Cretu, who will share insights about their experiences with hepatitis delta, and will speak specifically to their navigation of a hepatitis delta diagnosis and management. The webinar will be held on Wednesday, November 5th at 10am EST/4pm CET. We hope to see you there!”
Hep Free 2030: Data Workgroup @12PM HST
Letʻs get DATA!
Join our monthly Data workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Data workgroup focuses on projects related to surveillance, electronic reporting, qualitative research, and more!
This workgroup usually meets every 1st Tuesday. For more info on joining, email Myriam Saboui: myriam.saboui@doh.hawaii.gov.
Protecting Your Child: A Parent's Guide to Immunizations @4PM HST
Please join the virtual 1-hour collaborative learning session on Immunization Education on October 30, at 4 PM HST, led by Alice Luck, CEO of Kauai Planning and Action Alliance (KPAA).
The session is designed for parents and caregivers of newborns, children, and adolescents. We would love for you, your community partners, DOH colleagues, and local hepatitis organizations to attend this virtual event. Attendees who complete the surveys during the session will also have the opportunity to receive a gift card.
Session Details:
Date: Thursday, October 30, 2025
Time: 4:00 PM HST
Location: Virtual (Zoom link provided upon registration)
Amazon E-Gift Card: $10 for completing surveys
The session will cover:
Preventing vaccine-preventable diseases
Promoting current vaccination guidelines
Building parents’ and guardians’ trust and understanding
Enhancing vaccine access and equity for keiki
Hep B United Virtual Mini-Summit @6AM HST
“Join us for a two-day, potluck-style virtual mini-summit where partner organizations, advocates, and community leaders gather to share stories, strategies, and support across the hepatitis B spectrum. Enjoy interactive sessions, cultural networking spaces, and food recipe videos that celebrate the rich diversity of our communities.”
Hep B United Virtual Mini-Summit @6AM HST
“Join us for a two-day, potluck-style virtual mini-summit where partner organizations, advocates, and community leaders gather to share stories, strategies, and support across the hepatitis B spectrum. Enjoy interactive sessions, cultural networking spaces, and food recipe videos that celebrate the rich diversity of our communities.”
Defend Public Health General Assembly on Vaccines @11AM HST
“Join us on Tuesday, October 28th at 5PM Eastern for our next Defend Public Health General Assembly Meeting!
The meeting will include a presentation and Q&A with Dr. Paul Offit, Director of the Vaccine Education Center and professor of pediatrics in the Division of Infectious Diseases at Children’s Hospital of Philadelphia. Dr. Offit has been a champion for vaccination for his entire career and will discuss the current threats to immunization in the United States.
We will also hear about some of the exciting updates from the community organizing work from DPH State Organizing Teams. The movement that they are driving is inspiring.
Please register for the meeting by signing up here, and we will send you a zoom link and calendar invite to follow shortly!
We haven’t had a General Assembly in a few months, but will be planning to host them monthly going forward.
Onward!”
Hawai'i Hep B ECHO @12PM HST
Project ECHO: Hawai'i Hepatitis B 2025 starts Monday, September 8 for 8 weekly interactive learning sessions on Zoom.
The free series aims to strengthen screening, management, and treatment capacity for Hepatitis B virus (HBV) among healthcare providers in Hawaiʻi. The series will promote best practices, foster healthcare team collaboration, and patient considerations.
Continuing education credits (CME, CNE, CPE) will be available at no cost. Topics will include:
Hepatitis B in Hawaiʻi
Hepatitis B Screening and Diagnosis/ Family Counseling
Evaluation of Chronic Hepatitis B (incl. Fibrosis and Cirrhosis)
Hepatitis B Treatment
Cancer Surveillance and Liver Transplant
Fatty Liver and Hepatitis B
Hepatitis B Reactivation
Perinatal Transmission
Adult Immunizations
Hep C Point-of-Care RNA Testing and Test-and-Treat Models @6:30AM HST
HCV Treatment Education Training Implementing HCV Point-of-Care RNA Testing and Test-and-Treat Models
“Topics:
HCV Point-of-Care RNA testing
Simplified HCV Testing
Implementing Test-and-Treat Models
Community-based HCV testing and treatment
Improving HCV treatment access in people experiencing homelessness and people who use drugs”
Hep Free 2030: Access Workgroup @12PM HST
Letʻs get ACCESS!
Join our monthly Access workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Access workgroup focuses on projects related to immunization, testing, linkage, treatment, and provider education!
This workgroup usually meets every 3rd Tuesday. For more info on joining, email Thaddeus Pham: thaddeus.pham@doh.hawaii.gov